Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Reproducibility of FDG SUVmax for metastatic breast cancer lesions in the same or different PET/CT scanners in a local network

By Lanell M Peterson1, Brenda F. Kurland2, Andrew T Shields1, Darrin Byrd1, Alena Novakova3, Rebecca Christopel1, Mark Muzi1, David A. Mankoff4, Hannah M. Linden3, Paul Kinahan1

1. University of Washington 2. University of Pittsburgh 3. Seattle Cancer Care Alliance 4. University of Pennsylvania

Download (PPTX)

Licensed under

Published on

Abstract

Accurate reproducibility of PET SUVs is important for patient management and for clinical trial design. Measuring and reducing SUV variability in PET scanners throughout a local area network can aid in monitoring patient response to therapy and may increase patient accrual to clinical trials

Cite this work

Researchers should cite this work as follows:

  • Lanell M Peterson; Brenda F. Kurland; Andrew T Shields; Darrin Byrd; Alena Novakova; Rebecca Christopel; Mark Muzi; David A. Mankoff; Hannah M. Linden; Paul Kinahan (2014), "Reproducibility of FDG SUVmax for metastatic breast cancer lesions in the same or different PET/CT scanners in a local network ," https://ncihub.cancer.gov/resources/325.

    BibTex | EndNote